Evoke Pharma (EVOK) Tops Q3 EPS by 11c

Evoke Pharma (NASDAQ: EVOK) reported Q3 EPS of ($0.51), $0.11 better than the analyst estimate of ($0.62). Revenue for the quarter came in at $1.56 million versus the consensus estimate of $1.26 million.

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
• Daqo New Energy (DQ) Misses Q2 EPS by 67c
• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance